The Chicago Entrepreneur

Cidara Therapeutics shares surge 30% after reacquiring flu treatment

Shares of Cidara Therapeutics rose sharply after the company announced a reshuffling of its portfolio of drug candidates.

Previous post A new wave of e-commerce disruption could close 45,000 retail stores over the next five years, analysts say
Next post Acrivon Therapeutics’ shares climb 14% on plans to present cancer-test data